We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROST icon
476
Ross Stores
ROST
$80.6B
$2.75M 0.02%
24,041
+1,583
+7% +$177K
MAR icon
477
Marriott International
MAR
$98.7B
$2.75M 0.02%
16,616
-3,275
-16% -$515K
CFG icon
478
Citizens Financial Group
CFG
$30.3B
$2.73M 0.02%
57,818
-178,924
-76% -$8.62M
PSX icon
479
Phillips 66
PSX
$84.2B
$2.73M 0.02%
37,639
-5,464
-13% -$413K
STZ icon
480
Constellation Brands
STZ
$22.2B
$2.7M 0.02%
10,775
-2,874
-21% -$655K
HAL icon
481
Halliburton
HAL
$26.7B
$2.67M 0.02%
116,979
-151,398
-56% -$3.59M
CLX icon
482
Clorox
CLX
$11.6B
$2.64M 0.02%
15,156
+2,533
+20% +$422K
DPZ icon
483
Domino's
DPZ
$11.4B
$2.64M 0.02%
4,673
+3,436
+278% +$1.75M
EOG icon
484
EOG Resources
EOG
$78.2B
$2.64M 0.02%
29,670
-5,065
-15% -$455K
MSCI icon
485
MSCI
MSCI
$41.6B
$2.62M 0.02%
4,269
-23
-0.5% -$14.4K
ULTA icon
486
Ulta Beauty
ULTA
$21.9B
$2.59M 0.02%
6,277
-549
-8% -$213K
DLR icon
487
Digital Realty Trust
DLR
$70.6B
$2.58M 0.02%
14,611
+654
+5% +$105K
NDSN icon
488
Nordson
NDSN
$16.5B
$2.58M 0.02%
+10,093
New +$2.58M
WELL icon
489
Welltower
WELL
$170B
$2.57M 0.02%
30,005
-6,124
-17% -$511K
SWAV
490
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$2.57M 0.02%
+14,400
New +$2.84M
CTSH icon
491
Cognizant
CTSH
$24.2B
$2.56M 0.02%
28,903
-5,172
-15% -$416K
WU icon
492
Western Union
WU
$2.08B
$2.55M 0.02%
142,882
+26,177
+22% +$483K
NUVB icon
493
Nuvation Bio
NUVB
$2.25B
$2.52M 0.02%
295,935
+8,836
+3% +$81.2K
KRTX
494
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$2.5M 0.02%
19,056
-35,694
-65% -$4.61M
AIZ icon
495
Assurant
AIZ
$13.9B
$2.49M 0.02%
15,949
-1,255
-7% -$199K
MOS icon
496
The Mosaic Company
MOS
$7.07B
$2.45M 0.02%
62,430
+6,720
+12% +$257K
HON icon
497
Honeywell
HON
$76.6B
$2.45M 0.02%
12,446
-6,802
-35% -$1.37M
AME icon
498
Ametek
AME
$55.4B
$2.41M 0.02%
16,407
-4,288
-21% -$587K
PHM icon
499
Pultegroup
PHM
$24.2B
$2.41M 0.02%
42,172
-2,187
-5% -$112K
MCHP icon
500
Microchip Technology
MCHP
$40.9B
$2.39M 0.02%
27,473
-4,639
-14% -$375K
18 19
20
21 22

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.